James B. Johnston

7.3k total citations · 1 hit paper
195 papers, 5.4k citations indexed

About

James B. Johnston is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, James B. Johnston has authored 195 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Genetics, 64 papers in Molecular Biology and 50 papers in Pathology and Forensic Medicine. Recurrent topics in James B. Johnston's work include Chronic Lymphocytic Leukemia Research (87 papers), Lymphoma Diagnosis and Treatment (43 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). James B. Johnston is often cited by papers focused on Chronic Lymphocytic Leukemia Research (87 papers), Lymphoma Diagnosis and Treatment (43 papers) and Immunodeficiency and Autoimmune Disorders (19 papers). James B. Johnston collaborates with scholars based in Canada, United States and United Kingdom. James B. Johnston's co-authors include Grant McFadden, Christopher Power, Spencer B. Gibson, John W. Barrett, Steven H. Nazarian, Asher Begleiter, Henry A. Lardy, Robert I. Glazer, Craig R. Brunetti and Helen Everett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

James B. Johnston

190 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Poxviruses and Immune Evasion

2003 505 citations James B. Johnston et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James B. Johnston Canada	41	2.0k	1.3k	1.1k	1.1k	1.0k	195	5.4k
Ping Qiu United States	36	1.8k 0.9×	711 0.6×	2.4k 2.3×	299 0.3×	222 0.2×	156	7.1k
Roger W. Wiseman United States	46	3.4k 1.7×	1.6k 1.3×	547 0.5×	144 0.1×	854 0.8×	154	7.2k
Ping Chen China	35	2.2k 1.1×	906 0.7×	597 0.6×	145 0.1×	357 0.3×	189	4.7k
Jonathan M. Gibbins United Kingdom	48	2.1k 1.1×	1.1k 0.9×	269 0.3×	465 0.4×	219 0.2×	197	7.1k
Lai Wang United States	41	6.7k 3.3×	2.9k 2.3×	1.3k 1.2×	218 0.2×	228 0.2×	152	10.0k
Robert W. Sobol United States	53	7.1k 3.5×	541 0.4×	586 0.6×	823 0.8×	185 0.2×	166	9.6k
Artin Mahboubi United States	18	4.3k 2.1×	1.9k 1.5×	425 0.4×	120 0.1×	282 0.3×	21	6.3k
Osamu Tanabe Japan	32	3.0k 1.5×	1.6k 1.3×	491 0.5×	692 0.7×	63 0.1×	130	6.0k
Nathalie Droin France	39	4.2k 2.1×	2.7k 2.2×	802 0.8×	602 0.6×	68 0.1×	109	7.8k
Francisco Navarro Spain	38	2.4k 1.2×	3.7k 2.9×	815 0.8×	108 0.1×	963 0.9×	96	7.5k

Countries citing papers authored by James B. Johnston

Since Specialization

Citations

This map shows the geographic impact of James B. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Johnston more than expected).

Fields of papers citing papers by James B. Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Johnston. The network helps show where James B. Johnston may publish in the future.

Co-authorship network of co-authors of James B. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Johnston. A scholar is included among the top collaborators of James B. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Johnston. James B. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Xiaoyan, et al.. (2024). Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy. Cells. 13(12). 1041–1041. 3 indexed citations

Wedner, H. James, Takao Fujisawa, Theresa W. Guilbert, et al.. (2024). Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety ( TATE study). Pediatric Allergy and Immunology. 35(3). e14092–e14092. 16 indexed citations

Wu, Xun, Sen Hou, Spencer B. Gibson, et al.. (2023). Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment. Leukemia Research. 131. 107315–107315. 4 indexed citations

Cheung, TT, Yen Lin Chia, Chi‐Ho Lee, et al.. (2023). Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants. Drug Design Development and Therapy. Volume 17. 209–218. 4 indexed citations

Yang, Jiayu, Lin Yang, Oliver Bucher, et al.. (2023). Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade. Current Oncology. 30(7). 6411–6431.

Chowdhury, Subir Roy, Amandeep Singh, James B. Johnston, et al.. (2021). Ex Vivo Mitochondrial Respiration Parallels Biochemical Response to Ibrutinib in CLL Cells. Cancers. 13(2). 354–354. 2 indexed citations

Chowdhury, Subir Roy, Zoann Nugent, Edgard M. Mejia, et al.. (2020). Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment. Cancers. 12(3). 650–650. 17 indexed citations

Righolt, Christiaan H., Geng Zhang, Xibiao Ye, et al.. (2019). Statin Use and Chronic Lymphocytic Leukemia Incidence: A Nested Case–Control Study in Manitoba, Canada. Cancer Epidemiology Biomarkers & Prevention. 28(9). 1495–1501. 9 indexed citations

Guan, Qingdong, Xun Wu, Versha Banerji, et al.. (2019). Expression and function of phosphoinositide 3‐kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow. British Journal of Haematology. 185(5). 883–887. 5 indexed citations

10.

Ishdorj, Ganchimeg, Pascal Lambert, Salaheddin M. Mahmud, et al.. (2019). IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia. Blood Advances. 3(14). 2188–2198. 20 indexed citations

11.

Li, Hongzhao, Xun Wu, Sen Hou, et al.. (2015). Phosphatidylinositol-3,4-Bisphosphate and Its Binding Protein Lamellipodin Regulate Chemotaxis of Malignant B Lymphocytes. The Journal of Immunology. 196(2). 586–595. 14 indexed citations

12.

Beauchemin, C., et al.. (2015). Relationship between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia: A Literature-Based Analysis. Current Oncology. 22(3). 148–156. 24 indexed citations

13.

Gehrke, Iris, et al.. (2014). On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells. Clinical Cancer Research. 20(18). 4861–4872. 61 indexed citations

14.

Ishdorj, Ganchimeg, Bonnie A. Graham, Xiaojie Hu, et al.. (2008). Lysophosphatidic Acid Protects Cancer Cells from Histone Deacetylase (HDAC) Inhibitor-induced Apoptosis through Activation of HDAC. Journal of Biological Chemistry. 283(24). 16818–16829. 30 indexed citations

15.

Henson, Elizabeth S., James B. Johnston, & Spencer B. Gibson. (2008). The role of TRAIL death receptors in the treatment of hematological malignancies. Leukemia & lymphoma. 49(1). 27–35. 41 indexed citations

16.

Kubes, Paul, Bryan Heit, Guido van Marle, et al.. (2003). In Vivo Impairment of Neutrophil Recruitment during Lentivirus Infection. The Journal of Immunology. 171(9). 4801–4808. 30 indexed citations

17.

Johnston, James B., Paul Daeninck, G. J. Williams, et al.. (1997). P53, MDM-2, BAX and BCL-2 and Drug Resistance in Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 26(5-6). 435–449. 64 indexed citations

18.

Ji, Wei, et al.. (1993). A Multifunctional Decision Support GIS for Coastal Management. 94–105. 2 indexed citations

19.

Johnston, James B., et al.. (1991). USFWS Selected Geographic Analyses. 1968–1980. 1 indexed citations

20.

Johnston, James B., et al.. (1983). The Use of a GIS for Gulf of Mexico Wetland Change. 362–371. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact